Market revenue in 2022 | USD 92.3 million |
Market revenue in 2030 | USD 1,009.5 million |
Growth rate | 34.9% (CAGR from 2022 to 2030) |
Largest segment | Deep learning |
Fastest growing segment | Natural language processing |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.69% in 2022. Horizon Databook has segmented the Middle East & Africa artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
Middle Eastern countries such as Qatar, Saudi Arabia, Kuwait, Oman, and UAE are prospering economies. Advancements in the healthcare system are expected to boost the development of AI in precision medicine in these countries. On the contrary, some countries in the African region score low in healthcare IT readiness, which means that they lack infrastructure.
However, countries are undertaking initiatives in coordination with WHO or other independent organizations. This is expected to boost the penetration of AI in precision medicine services. The Gulf Cooperation Council (GCC) includes Saudi Arabia, Bahrain, Oman, Qatar, the UAE, and Kuwait.
Moreover, key strategies, such as partnerships, and new launches, by market players are likely to drive the market in MEA. For instance, in May 2021, BC Platforms, a global healthcare data analytics and data management company, announced its partnership with Artisan (Artisan Biomed), a provider of genomics services and health solutions, for the development of precision medicine in South Africa.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa artificial intelligence in precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account